Table 1 Clinicopathologic characteristics of 275 patients included in our study
From: Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
Characteristics | No. of patients (%) |
|---|---|
Sex | Â |
 Male | 223 (81.1) |
 Female | 52 (18.9) |
Age (year) (36–78 year; median 57 year) |  |
 ≤60 | 180 (65.5) |
 <60 | 95 (34.5) |
Tumor location | Â |
 Upper | 37 (13.5) |
 Middle | 175 (63.6) |
 Lower | 63 (22.9) |
Tumor length | Â |
 <5 cm | 123 (44.7) |
 ≥5 cm | 152 (55.3) |
Tumor differentiation | Â |
 Well differentiated | 26 (9.5) |
 Moderately differentiated | 184 (66.9) |
 Poorly differentiated | 65 (23.6) |
Pathologic T stage | Â |
 T1 | 13 (4.7) |
 T2 | 100 (36.4) |
 T3 | 127 (46.2) |
 T4 | 35 (12.7) |
Pathologic N stage | Â |
 N0 | 101 (36.7) |
 N1 | 74 (26.9) |
 N2 | 71 (25.8) |
 N3 | 29 (10.5) |
Pathologic TNM stage | Â |
 I | 11 (4.0) |
 II | 120 (43.6) |
 III | 144 (52.4) |
Adjuvant therapy | Â |
 None | 106 (38.5) |
 Radiotherapy | 10 (3.6) |
 Chemotherapy | 83 (30.2) |
 Chemoradiotherapy | 50 (18.2) |
 Unknown | 26 (9.5) |